News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aeras and China National Biotech Group Partner on TB Vaccine



1/10/2012 11:26:31 AM

January 10, 2012 -- Aeras, a US-based non-profit dedicated to developing effective TB vaccines and biologics, has partnered with the China National Biotec Group (CNBG) to develop a recombinant form of Bacille Calmette-Guerin (BCG), the only TB vaccine currently approved. Aeras will provide financial support and technical expertise to CNBG as part of the partnership. More details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES